Evidence map›Paper›PMID 30496103›Full record

ArticleLancet (London, England)2018

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Causes of Death Collaborators

Erratum issued 10 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 10 registered trials, which are not on this map. Cited by 4,016 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4,016citing papers in PubMed, 11 pooled it
1447.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04182321 nacompletednot on this mapstarted 2020, after this paper: background citation

Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis B: A Randomized, Double-Blind, Placebo-Controlled Trial

TypeinterventionalSponsorFu-Sheng WangRan2020 to 2021Enrolled60ConditionsChronic Hepatitis BArmsMetformin & Entecavir, Placebo & Entecavir
NCT04432194 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Evaluation of the Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of Patients With Heart Failure and Chronic Obstructive Pulmonary Disease

TypeinterventionalSponsorInstituto Nacional de Enfermedades RespiratoriasRan2019 to 2023Enrolled100ConditionsHeart Failure, Copd, Nutritional Supplementation, Pulmonary RehabilitationArmsNutritional supplementation and Pulmonary Rehabilitation
NCT04845269 completednot on this mapstarted 2021, after this paper: background citation

Post-Stroke Osteopathy: Characterization of Fractures and Changes in the Bone Microstructure After Ischemic Stroke or TIA

TypeobservationalSponsorVASCage GmbHRan2021 to 2023Enrolled127ConditionsStroke (CVA) or TIA, Fracture, Fall
NCT05252780 nacompletednot on this mapstarted 2019, after this paper: background citation

"My Body, My Rhythm, My Voice": a Community Dance Intervention Engaging Breast Cancer Survivors in Physical Activity in a Middle-income Country

TypeinterventionalSponsorOlga Lucia SarmientoRan2019 to 2020Enrolled64ConditionsPhysical Inactivity, Breast CancerArmsMy Body, My Rhythm, My Voice
NCT05632432 narecruitingnot on this mapstarted 2024, after this paper: background citation

Autologous Atrial Appendage Micrografts Transplanted During Coronary Artery Bypass Surgery: the AAMS2 Randomized, Double-blinded, and Placebo-controlled Trial

TypeinterventionalSponsorHospital District of Helsinki and UusimaaRan2024 to 2026Enrolled50ConditionsIschemic Heart Disease, Ischemic Cardiomyopathy, Heart Failure, Systolic, Heart Failure NYHA Class IIIArmsEpicardial AAMs-patch transplantation, RNA-stabilized whole blood sampling, Plasma sampling, Transthoracic echocardiography, Late-gadolinium enhancement cardiac magnetic resonance imaging (LGE-CMRI)
NCT05714241 recruitingnot on this mapstarted 2022, after this paper: background citation

BIOmarkers and PLAtelet Function Assessment in Myocardial Ischemia and Non Obstructive Coronary Arteries Study: The BIOplatINO Study

TypeobservationalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2022 to 2027Enrolled200ConditionsIschemia With no Obstructive Coronary Artery DiseaseArmsData extraction, Blood sampling, Clinical Follow-up
NCT06075108 narecruitingnot on this mapstarted 2024, after this paper: background citation

P-KIDs CARE: An Intervention to Address Health Systems Delays to Care for Injured Children in Tanzania

TypeinterventionalSponsorUniversity of UtahRan2024 to 2028Enrolled284ConditionsAccidental Injuries, Global Child Health, Pediatric Emergency Medicine, Public Health System ResearchArmsP-KIDs CARE
NCT06836804 completednot on this mapstarted 2025, after this paper: background citation

Validity and Reliability Study of the Turkish Long and Short Forms of the Cardiac Depression Scale

TypeobservationalSponsorKırıkkale UniversityRan2025 to 2026Enrolled360ConditionsCardiovascular Diseases, DepressionArmsSociodemographic Data Form, Short Form Health Survey, Hospital Anxiety and Depression Scale, Illness Intrusiveness Ratings Scale, Cardiac Depression Scale
NCT07149961 nacompletednot on this mapstarted 2025, after this paper: background citation

Supplementation of Piperine and Curcumin (Curcuma Xanthorrhiza) Extract in ST Elevation Myocardial Infarction - SPICE STEMI Trial

TypeinterventionalSponsorUniversitas DiponegoroRan2025 to 2025Enrolled50ConditionsST Elevation Myocardial Infarction (STEMI), Malondialdehyde, Hs-CRP, CurcuminArmsCurcumin plus Piperine, Placebo capsules
NCT07592962 recruitingnot on this mapstarted 2026, after this paper: background citation

Whole-life Investigation of Lishui Longevity Cohort Study

Typeobservational_patient_registrySponsorThe Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central HospitalRan2026 to 2036Enrolled4,500ConditionsIschemic Stroke, Chronic Disease, Cardiovascular
3 · Its place in the literature

Who cites it

4,016 citing papers in PubMed, 11 syntheses or guidelines pooled it, 8,565 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Palliative care interventions for thoracic cancer: a systematic review and meta-analysis identifying the core elements.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Review

3,956 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

GBD 2017 Causes of Death Collaborators
Institute for Health Metrics and Evaluation · US

Funding

University of Washington Center for Demography and Economics of Aging-OverallP30AG047845 · NIA · UNIVERSITY OF WASHINGTON · PI MURRAY, CHRISTOPHER J.L. · 2014 to 2019
$3.8M
Methodologies to Enhance Understanding of HIV-Associated Social DeterminantsR01MH110163 · NIMH · UNIVERSITY OF WASHINGTON · PI WANG, HAIDONG · 2016 to 2020
$1.9M
Mapping impact and developing mitigation strategies for climate change-mental health nexus in the context of vulnerable adolescent populations in KenyaK43TW010716 · FIC · UNIVERSITY OF NAIROBI · PI KUMAR, MANASI · 2018 to 2022
$648k
British Heart Foundation RG/13/13/30194Chief Scientist Office SCAF/15/02FIC NIH HHS K43 TW010716Medical Research Council MC_UU_12026/2Medical Research Council MR/L003120/1Medical Research Council MR/M015084/1Medical Research Council MR/R015600/1NIA NIH HHS P30 AG047845NIMH NIH HHS R01 MH110163Wellcome Trust 201900Wellcome Trust 201900/Z/16/ZWellcome Trust 206471/Z/17/Z
6 · The paper itself

Abstract

backgroundGlobal development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017.

methodsThe causes of death database is composed of vital registration (VR), verbal autopsy (VA), registry, survey, police, and surveillance data. GBD 2017 added ten VA studies, 127 country-years of VR data, 502 cancer-registry country-years, and an additional surveillance country-year. Expansions of the GBD cause of death hierarchy resulted in 18 additional causes estimated for GBD 2017. Newly available data led to subnational estimates for five additional countries-Ethiopia, Iran, New Zealand, Norway, and Russia. Deaths assigned International Classification of Diseases (ICD) codes for non-specific, implausible, or intermediate causes of death were reassigned to underlying causes by redistribution algorithms that were incorporated into uncertainty estimation. We used statistical modelling tools developed for GBD, including the Cause of Death Ensemble model (CODEm), to generate cause fractions and cause-specific death rates for each location, year, age, and sex. Instead of using UN estimates as in previous versions, GBD 2017 independently estimated population size and fertility rate for all locations. Years of life lost (YLLs) were then calculated as the sum of each death multiplied by the standard life expectancy at each age. All rates reported here are age-standardised.

findingsAt the broadest grouping of causes of death (Level 1), non-communicable diseases (NCDs) comprised the greatest fraction of deaths, contributing to 73·4% (95% uncertainty interval [UI] 72·5-74·1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional (CMNN) causes accounted for 18·6% (17·9-19·6), and injuries 8·0% (7·7-8·2). Total numbers of deaths from NCD causes increased from 2007 to 2017 by 22·7% (21·5-23·9), representing an additional 7·61 million (7·20-8·01) deaths estimated in 2017 versus 2007. The death rate from NCDs decreased globally by 7·9% (7·0-8·8). The number of deaths for CMNN causes decreased by 22·2% (20·0-24·0) and the death rate by 31·8% (30·1-33·3). Total deaths from injuries increased by 2·3% (0·5-4·0) between 2007 and 2017, and the death rate from injuries decreased by 13·7% (12·2-15·1) to 57·9 deaths (55·9-59·2) per 100 000 in 2017. Deaths from substance use disorders also increased, rising from 284 000 deaths (268 000-289 000) globally in 2007 to 352 000 (334 000-363 000) in 2017. Between 2007 and 2017, total deaths from conflict and terrorism increased by 118·0% (88·8-148·6). A greater reduction in total deaths and death rates was observed for some CMNN causes among children younger than 5 years than for older adults, such as a 36·4% (32·2-40·6) reduction in deaths from lower respiratory infections for children younger than 5 years compared with a 33·6% (31·2-36·1) increase in adults older than 70 years. Globally, the number of deaths was greater for men than for women at most ages in 2017, except at ages older than 85 years. Trends in global YLLs reflect an epidemiological transition, with decreases in total YLLs from enteric infections, respiratory infections and tuberculosis, and maternal and neonatal disorders between 1990 and 2017; these were generally greater in magnitude at the lowest levels of the Socio-demographic Index (SDI). At the same time, there were large increases in YLLs from neoplasms and cardiovascular diseases. YLL rates decreased across the five leading Level 2 causes in all SDI quintiles. The leading causes of YLLs in 1990-neonatal disorders, lower respiratory infections, and diarrhoeal diseases-were ranked second, fourth, and fifth, in 2017. Meanwhile, estimated YLLs increased for ischaemic heart disease (ranked first in 2017) and stroke (ranked third), even though YLL rates decreased. Population growth contributed to increased total deaths across the 20 leading Level 2 causes of mortality between 2007 and 2017. Decreases in the cause-specific mortality rate reduced the effect of population growth for all but three causes: substance use disorders, neurological disorders, and skin and subcutaneous diseases.

interpretationImprovements in global health have been unevenly distributed among populations. Deaths due to injuries, substance use disorders, armed conflict and terrorism, neoplasms, and cardiovascular disease are expanding threats to global health. For causes of death such as lower respiratory and enteric infections, more rapid progress occurred for children than for the oldest adults, and there is continuing disparity in mortality rates by sex across age groups. Reductions in the death rate of some common diseases are themselves slowing or have ceased, primarily for NCDs, and the death rate for selected causes has increased in the past decade.

fundingBill & Melinda Gates Foundation.

Indexed as

Life ExpectancyAdolescentAdultAgedAged, 80 and overAge DistributionCause of DeathChildChild, PreschoolFemaleGlobal Burden of DiseaseGlobal HealthHumansInfantInfant, NewbornMale

Identifiers

PMID30496103
PMCPMC6227606
OpenAlexW2899736836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 4 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.